Palisade Bio
PALI
8 hedge funds and large institutions have $489K invested in Palisade Bio in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
36% more capital invested
Capital invested by funds: $360K → $489K (+$129K)
33% more funds holding
Funds holding: 6 → 8 (+2)
0% less ownership
Funds ownership: 0% → 0% (-0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$57.8K |
| 2 |
HF
HRT Financial
New York
|
+$10.8K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$10.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $320K | +$57.8K | +16 | +19% |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $83K | – | – | – |
|
3
Bank of New York Mellon
New York
| $34K | – | – | – |
|
|
VF
4
Virtu Financial
New York
| $23K | +$25.3K | +7 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $10K | +$7.22K | +2 | +200% |
|
|
6
Northern Trust
Chicago,
Illinois
| $9K | +$10.8K | +3 | New |
|
|
HF
7
HRT Financial
New York
| $8K | +$10.8K | +3 | New |
|
8
BlackRock
New York
| $2K | – | – | – |
|
|
9
Victory Capital Management
San Antonio,
Texas
| – | -$2K | -1 | Closed |
|
PALI Hedge Fund Activity: Q2 2020 in Review
8 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q2 2020, worth a combined $489K — up 36% from $360K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PALI positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $57.8K. The largest seller was Victory Capital Management, exiting entirely with an estimated $2K sold.
- 8 institutional investors held Palisade Bio (PALI) as of Q2 2020, up from 6 in Q1 2020.
- Funds reported $489K of Palisade Bio stock for Q2 2020, up 36% quarter-over-quarter.
- 3 funds opened new Palisade Bio positions in Q2 2020 and 1 closed out, a net change of +2 holders.
- The largest Palisade Bio buyer in Q2 2020 was Renaissance Technologies, an estimated $57.8K added.
- The largest Palisade Bio seller in Q2 2020 was Victory Capital Management, an estimated $2K sold.
Based on aggregated 13F filings for Q2 2020.